11/18
08:30 am
imrn
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
Low
Report
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
10/16
06:00 am
imrn
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
Low
Report
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
10/15
06:00 am
imrn
Immuron Travelan® continued strong sales growth
Medium
Report
Immuron Travelan® continued strong sales growth
10/4
06:30 am
imrn
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
Low
Report
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
10/3
04:56 pm
imrn
Immuron Full Year 2024 Earnings: AU$0.03 loss per share (vs AU$0.017 loss in FY 2023) [Yahoo! Finance]
Low
Report
Immuron Full Year 2024 Earnings: AU$0.03 loss per share (vs AU$0.017 loss in FY 2023) [Yahoo! Finance]
9/19
09:46 am
imrn
Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma [Yahoo! Finance]
Low
Report
Traveler's Diarrhea Therapeutics Pipeline Market Report 2024 Featuring Immuron, Scandinavian Biopharma, and Sigmoid Pharma [Yahoo! Finance]
9/5
11:54 am
imrn
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Low
Report
Immuron Plans Phase 2 Trial for IMM-529 following FDA review